Rigrodsky
& Long, P.A. announces that it has initiated an investigation of
Centene Corporation (“Centene” or the “Company”) (NYSE: CNC)
during the period of February 7, 2012 through June 8, 2012, inclusive
(the “Relevant Period”) for possible violations of the federal
securities laws. The investigation arises from the Company’s
announcement in its June 11, 2012 press release that it is revising its
2012 guidance to $1.45 to $1.65 per diluted share, from the previously
announced range of $2.64 to $2.84 per diluted share. The revised
guidance range reflects negative financial results in May for the
Company’s Kentucky Health Plan and the Hidalgo service area of their
Texas Health Plan, as well as in the Celtic individual health business.
Additionally, per the press release, the Company is evaluating the
goodwill and intangible assets of its Celtic business unit which may
result in a non-cash impairment charge of approximately $28 million.
If you have any information concerning the foregoing, or wish to discuss
this investigation or your rights or interests, please contact Timothy
J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 825
East Gate Boulevard, Suite 300, Garden City, NY at (888) 969-4242, by
e-mail to info@rigrodskylong.com,
or at http://www.rigrodskylong.com/investigations/centene-corporation-cnc.
Rigrodsky
& Long, P.A., with offices in Wilmington, Delaware and Garden
City, New York, regularly
litigates securities class, derivative and direct actions, shareholder
rights litigation and corporate governance litigation, including
claims for breach of fiduciary duty and proxy violations in the Delaware
Court of Chancery and in state and federal courts throughout the United
States.
Attorney advertising. Prior results do not guarantee a similar outcome.
